1
|
Vilibic-Cavlek T, Tabain I, Kolaric B, Mihulja K, Blazevic L, Bogdanic M, Navolan D, Beader N, Mrzljak A. Parvovirus B19 in Croatia: A Large-Scale Seroprevalence Study. MEDICINA (KAUNAS, LITHUANIA) 2021; 57:medicina57111279. [PMID: 34833497 PMCID: PMC8617724 DOI: 10.3390/medicina57111279] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/01/2021] [Revised: 11/16/2021] [Accepted: 11/17/2021] [Indexed: 02/07/2023]
Abstract
Background and Objectives: Seroepidemiological studies indicate that parvovirus B19 circulates in all areas of the world, although with some differences. The aim of this study is to analyze the seroprevalence of parvovirus B19 in the Croatian population. Materials and Methods: From 2010 to 2021, 1538 serum samples from different populations were tested for the presence of parvovirus B19 IgM/IgG antibodies. Serological tests were performed using a commercial enzyme-linked immunosorbent assay. Results: IgG antibodies were detected in 986/64.1% of participants with differences (p < 0.001) among the following population groups: 42.4% of children and adolescents, 67.1% of the adult general population, 66.7% of hemodialysis patients, and 65.6% of liver transplant recipients. Seroprevalence increased with age, from 30.0% in the 6 months-9 years age group to 69.0% in the 40-49 years age group, and remained stable thereafter (68.8-73.3%). There was no difference in the seropositivity among males (66.1%) and females (63.1%), as well as the place of residence (suburban/rural 63.9%, urban 64.1%). IgM antibodies (current/recent infection) were found in 61/4.0% of participants with the highest seropositivity in the youngest age group (11.1%). In pregnant women, seroprevalence was higher in women with an unfavorable obstetric history compared with a normal pregnancy (IgG 71.0% vs. 62.6%; IgM 6.5% vs. 2.4%), but these differences were not significant. Logistic regression showed that the adult population had almost three times higher risk of IgG seropositivity compared to children/adolescents (general population OR = 2.777, 95% CI = 2.023-3.812; hemodialysis patients OR = 2.586, 95% CI = 1.531-4.367; and transplant patients OR = 2.717, 95% CI = 1.604-4.603). A one-year increase in age increased the risk of IgG seroprevalence (OR = 1.017; 95% CI = 1.011-1.022). Conclusions: Older age was the main risk factor for IgG seropositivity. Hemodialysis and organ transplantation seem unrelated to the increased parvovirus B19 seroprevalence. The role of parvovirus B19 in the etiology of TORCH infections needs to be studied further.
Collapse
Affiliation(s)
- Tatjana Vilibic-Cavlek
- Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia; (I.T.); (M.B.)
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia; (N.B.); (A.M.)
- Correspondence: ; Tel.: +385-1-4863-238
| | - Irena Tabain
- Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia; (I.T.); (M.B.)
| | - Branko Kolaric
- Department of Public Health Gerontology, Andrija Stampar Teaching Institute of Public Health, 10000 Zagreb, Croatia;
- Department of Epidemiology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Klara Mihulja
- Zagreb County Family Medicine Division, 10380 Sveti Ivan Zelina, Croatia;
| | - Lana Blazevic
- Department of Epidemiology, Croatian Institute of Public Health, 10000 Zagreb, Croatia;
| | - Maja Bogdanic
- Department of Virology, Croatian Institute of Public Health, 10000 Zagreb, Croatia; (I.T.); (M.B.)
| | - Dan Navolan
- Department of Obstetrics-Gynecology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania;
| | - Natasa Beader
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia; (N.B.); (A.M.)
- Department of Clinical and Molecular Microbiology, University Hospital Center, 10000 Zagreb, Croatia
| | - Anna Mrzljak
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia; (N.B.); (A.M.)
- Department of Gastroenterology and Hepatology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
| |
Collapse
|
2
|
Sabahi M, Salehipour A, Kazemi A, Sadeghi M, Decaro N, Mozhgani SH, Jalilian FA, Yaghoobi MH. Prevalence and disease association of human parvovirus B19 in Iran: a systematic review. Future Virol 2019. [DOI: 10.2217/fvl-2019-0046] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Aim: The prevalence of human parvovirus B19 (B19V) and its association with other diseases in Iran are yet to be systematically assessed. This study aimed to evaluate the prevalence and disease association of B19V across Iran from 2000 to 2019. Methods: The literature search, based on different keywords in different databases, was performed. A total of 29 eligible studies were included and the essential information was collected from each article. Results: The results of this study show a relatively high prevalence of the B19V-associated diseases in all age groups of the Iranian population. Conclusion: The transmission of B19V and its complications should be prevented by developing preventative strategies.
Collapse
Affiliation(s)
- Mohammadmahdi Sabahi
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
| | - Arash Salehipour
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
| | - Azin Kazemi
- Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
| | - Mohammadreza Sadeghi
- Department of Virology, Haartman Institute, University of Helsinki, Helsinki, Finland
| | - Nicola Decaro
- Department of Animal Health & Well-Being, Faculty of Veterinary Medicine of Bari, University of Bari, Bari, Italy
| | - Sayed-Hamidreza Mozhgani
- Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
| | - Farid Azizi Jalilian
- Department of Virology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
| | - Mojtaba Hedayat Yaghoobi
- Department of Infectious Disease, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
| |
Collapse
|
3
|
AKTAŞ O, AYDIN H, USLU H. Serological prevalence of human parvovirus B19 in diseases or disordersrelated to different human body systems. Turk J Med Sci 2016; 46:368-73. [DOI: 10.3906/sag-1409-79] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2014] [Accepted: 07/05/2015] [Indexed: 11/03/2022] Open
|
4
|
Bonjoch X, Obispo F, Alemany C, Pacha A, Rodríguez E, Xairó D. Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples. Transfus Med Hemother 2015; 42:233-8. [PMID: 26557815 DOI: 10.1159/000381979] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2014] [Accepted: 12/05/2014] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Accurate characterization of the infection stage in parvovirus B19(B19V)-positive plasma donations would help establish the donation deferral period to contribute to a safe fractionation pool of plasma. METHODS Viral DNA load of 74 B19V DNA-positive plasma samples from whole blood donations was determined by titration using nucleic acid testing. Markers of cellular (neopterin) and humoral (B19V-specific IgM and IgG) immune response were determined by ELISA in 32 B19V DNA-positive samples and in 13 B19V DNA-negative samples. The infection progression profile was estimated according to B19V DNA load and the presence of immune response markers. RESULTS B19V DNA load in the 74 samples was 10(6)-10(13) IU/ml. The distribution of 14 out of 32 selected B19V DNA-positive samples plus 2 B19V DNA-negative samples with no immune response marker followed along an upward curve according to B19V DNA load. After the peak, the distribution of 18 immune marker-positive samples followed along a downward curve according to their B19V DNA load and was grouped as follows: neopterin (n = 4), neopterin+ IgM (n = 8), neopterin + IgM + IgG (n = 3), IgM + IgG (n = 2), IgM (n = 1). There were 11 B19V DNA-negative IgG-positive samples. CONCLUSION This study of B19V-DNA load and levels of neopterin, IgM, and IgG allows for reliable characterization and distribution into the different stages of B19V infection.
Collapse
Affiliation(s)
- Xavier Bonjoch
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| | - Francesc Obispo
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| | - Cristina Alemany
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| | - Ana Pacha
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| | - Esteban Rodríguez
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| | - Dolors Xairó
- Analysis Division, Grifols, Biomat S.A., Parets del Vallès, Barcelona, Spain
| |
Collapse
|
5
|
Hannachi N, Marzouk M, Harrabi I, Ferjani A, Ksouri Z, Ghannem H, Khairi H, Hidar S, Boukadida J. Séroépidémiologie de la rubéole, de la varicelle et des infections par le cytomégalovirus et le parvovirus B19 chez les femmes enceintes dans la région de Sousse, Tunisie. ACTA ACUST UNITED AC 2011; 104:62-7. [DOI: 10.1007/s13149-010-0119-z] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2010] [Accepted: 10/12/2010] [Indexed: 11/28/2022]
|